Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2012 075 017.0 |
96 | EP file number | EAKZ | 12 79 3812.4 |
86 | WO file number | WAKZ | PCT/US2012/040733 |
97 | EP publication number | EPN | 2713727 |
87 | WO publication number | WPN | 2012167247 |
54 | Designation/title | TI | KOMBINATION AUS MEK-HEMMERN UND SELEKTIVEN HEMMERN DER AURORA-A-KINASE |
51 | IPC main class | ICM (ICMV) | A61K 45/06 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/519 (2006.01), A61K 31/55 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Jun 4, 2012 |
96 | EP application date | EAT | Jun 4, 2012 |
86 | WO application date | WAT | Jun 4, 2012 |
43 | Date of first publication | OT | Dec 6, 2012 |
| Date of publication of grant | PET | Mar 31, 2021 |
71/73 | Applicant/owner | INH | Millennium Pharmaceuticals, Inc., Cambridge, MA, US |
72 | Inventor | IN | CHAKRAVARTY, Arijit, Lexington, MA 02420, US; VINCENT, Patrick, San Diego, CA 92121, US |
| Address for service | | Kilburn & Strode LLP, London WC1X 8NL, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261613207 P Mar 20, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201161493217 P Jun 3, 2011
|
| Due date | FT FG | Jun 30, 2025 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002713727 Searchable text:
EP000002713727 Original document:
EP000002713727B1 Searchable text:
EP000002713727B1 Original document:
WO002012167247 Searchable text:
WO002012167247 |
43 | Date of first publication | EVT | Dec 6, 2012 |
| Date of the first transfer into DPMAregister | EREGT | May 23, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 19, 2024 (Show all update days)(Hide all update days)- Sep 19, 2024
- St.36: changed (technical change)
- Jul 10, 2024; May 28, 2024; May 9, 2024; Jun 3, 2023; May 25, 2023; Apr 29, 2023; May 26, 2022; Mar 24, 2022; Feb 17, 2022; Aug 3, 2021; Apr 15, 2021; Mar 11, 2021; Dec 6, 2018
- Historical data not available for this/these date(s)
- May 23, 2014
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Apr 28, 2023 |
| Issue number | HN | 23 |
| Year | PJ | 2023 |
| Publication date | VT | Jun 7, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Millennium Pharmaceuticals, Inc., Cambridge, MA, US |
71/73 | Previous applicant/owner | INHF | Millennium Pharmaceuticals, Inc., Cambridge, Mass., US, Takeda Pharmaceutical Company Ltd., Kanagawa, JP |
| Date of update of the procedure | REGT | May 25, 2023 |